Webb1 juli 2024 · Piqray® (alpelisib) (Oral) Document Number: IC-0480 Last Review Date: 07/01/2024 Date of Origin: 07/01/2024 Dates Reviewed: 07/2024 I. Length of Authorization Coverage will be provided for six months and may be renewed. II. Dosing Limits A. Quantity Limit (max daily dose) [Pharmacy Benefit]: Webblycemia: Hyperglycaemia was reported in of patients treated with Piqray in the phase III clinical study. Patients with poor glycemic control may be at a higher risk of developing severe hyperglycaemia and associated complications (e.g. ketoacidosis). Patients should be advised of the signs and symptoms of hy- perglycemia.
Mechanism of Action PIQRAY® (alpelisib) tablets HCP - Novartis
WebbHyperglycemia was reported in 65% of patients treated with PIQRAY. Grade 3 (FPG >250-500 mg/dL) and grade 4 (FPG >500 mg/dL) hyperglycemia were reported in 33% and 3.9% of patients, respectively. Ketoacidosis was reported in 0.7% of … Webbo If hyperglycemia develops, discuss initiation of metformin dosing with the provider as well as dose interruption and reductions (see supplemental information) o Provide patient with the prescription for a home glucometer (new ICD-10 Code R09.65 Drug and Chemical induced diabetes mellitus with hyperglycemia) and counsel appropriately copy iphone photos to computer windows 10
Alpelisib-Induced Hyperglycemia- A Small Case Series
WebbHyperglycemia was reported in 65% of patients treated with PIQRAY. Grade 3 (FPG >250-500 mg/dL) and grade 4 (FPG >500 mg/dL) hyperglycemia were reported in 33% and 3.9% of patients, respectively. Ketoacidosis was reported in 0.7% of … WebbHyperglycemia was reported in 65% of patients treated with PIQRAY. Grade 3 (FPG >250-500 mg/dL) and grade 4 (FPG >500 mg/dL) hyperglycemia were reported in 33% and … WebbPIQRAY is a drug for treatment of adults with a specific form of advanced breast cancer that ... Subgroup Analysis of All grade (1-5) Hyperglycemia (safety population) Demographic ... famous people rejected